Fulgent Genetic Company Profile (NASDAQ:FLGT)

About Fulgent Genetic (NASDAQ:FLGT)

Fulgent Genetic logoFulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:FLGT
  • CUSIP: N/A
  • Web: www.fulgentgenetics.com
Capitalization:
  • Market Cap: $117.12 million
  • Outstanding Shares: 17,692,000
Average Prices:
  • 50 Day Moving Avg: $6.14
  • 200 Day Moving Avg: $9.51
  • 52 Week Range: $4.49 - $13.90
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 15.76
  • P/E Growth: 0.71
Sales & Book Value:
  • Annual Revenue: $20.14 million
  • Price / Sales: 5.82
  • Book Value: $3.13 per share
  • Price / Book: 2.12
Profitability:
  • EBIDTA: $3.13 million
  • Return on Equity: 0.21%
  • Return on Assets: 0.11%
Debt:
  • Current Ratio: 10.11%
  • Quick Ratio: 10.11%
Misc:
  • Average Volume: 49,257 shs.
  • Short Ratio: 2.13
 
Frequently Asked Questions for Fulgent Genetic (NASDAQ:FLGT)

What is Fulgent Genetic's stock symbol?

Fulgent Genetic trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetic's earnings last quarter?

Fulgent Genetic (NASDAQ:FLGT) announced its quarterly earnings results on Monday, May, 8th. The company reported $0.02 EPS for the quarter, missing the Zacks' consensus estimate of $0.03 by $0.01. The company had revenue of $5.31 million for the quarter, compared to analysts' expectations of $5.85 million. View Fulgent Genetic's Earnings History.

Where is Fulgent Genetic's stock going? Where will Fulgent Genetic's stock price be in 2017?

3 analysts have issued 12 month target prices for Fulgent Genetic's stock. Their forecasts range from $13.00 to $15.00. On average, they anticipate Fulgent Genetic's share price to reach $13.67 in the next year. View Analyst Ratings for Fulgent Genetic.

Who are some of Fulgent Genetic's key competitors?

Who are Fulgent Genetic's key executives?

Fulgent Genetic's management team includes the folowing people:

  • Ming Hsieh, Chairman of the Board, President, Chief Executive Officer
  • Paul Kim, Chief Financial Officer
  • Hanlin Gao M.D., Ph.D., Lab Director and Chief Scientific Officer
  • John Bolger, Director
  • James J. Mulay, Director
  • Yun Yen M.D., Ph.D., Director

When did Fulgent Genetic IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers.

How do I buy Fulgent Genetic stock?

Shares of Fulgent Genetic can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fulgent Genetic's stock price today?

One share of Fulgent Genetic stock can currently be purchased for approximately $6.62.


MarketBeat Community Rating for Fulgent Genetic (NASDAQ FLGT)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetic and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Fulgent Genetic (NASDAQ:FLGT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.67 (106.45% upside)

Analysts' Ratings History for Fulgent Genetic (NASDAQ:FLGT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/4/2016Credit Suisse GroupReiterated RatingBuy$13.00N/AView Rating Details
10/24/2016BTIG ResearchInitiated CoverageBuy$15.00N/AView Rating Details
10/24/2016Piper Jaffray CompaniesInitiated CoverageOverweight$13.00N/AView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Fulgent Genetic (NASDAQ:FLGT)
Earnings by Quarter for Fulgent Genetic (NASDAQ:FLGT)
Earnings History by Quarter for Fulgent Genetic (NASDAQ FLGT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q1 2017$0.03$0.02$5.85 million$5.31 millionViewListenView Earnings Details
2/27/2017Q416$0.04$0.05$5.99 million$5.85 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fulgent Genetic (NASDAQ:FLGT)
Current Year EPS Consensus Estimate: $0.16 EPS
Next Year EPS Consensus Estimate: $0.42 EPS

Dividends

Dividend History for Fulgent Genetic (NASDAQ:FLGT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Fulgent Genetic (NASDAQ:FLGT)
Institutional Ownership Percentage: 19.78%
Insider Trades by Quarter for Fulgent Genetic (NASDAQ:FLGT)
Institutional Ownership by Quarter for Fulgent Genetic (NASDAQ:FLGT)
Insider Trades by Quarter for Fulgent Genetic (NASDAQ:FLGT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2017Ming HsiehInsiderBuy20,000$5.26$105,200.00View SEC Filing  
6/13/2017Ming HsiehInsiderBuy30,000$4.98$149,400.00View SEC Filing  
9/30/2016Ming HsiehInsiderBuy1,000,000$9.00$9,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Fulgent Genetic (NASDAQ:FLGT)
Latest Headlines for Fulgent Genetic (NASDAQ:FLGT)
Source:
DateHeadline
americanbankingnews.com logoZacks: Fulgent Genetic (FLGT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 24 at 9:57 AM
americanbankingnews.com logoFulgent Genetic (NASDAQ:FLGT) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - July 10 at 7:14 PM
finance.yahoo.com logoETFs with exposure to Fulgent Genetics, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 6:34 PM
americanbankingnews.com logoCytosorbents Corporation (CTSO) and FULGENT GENETIC (FLGT) Head-To-Head Analysis
www.americanbankingnews.com - June 25 at 10:08 AM
finance.yahoo.com logoETFs with exposure to Fulgent Genetics, Inc. : June 16, 2017
finance.yahoo.com - June 16 at 5:53 PM
americanbankingnews.com logoFulgent Genetic (FLGT) Insider Acquires $105,200.00 in Stock
www.americanbankingnews.com - June 15 at 10:26 PM
americanbankingnews.com logo Brokerages Set $10.75 Price Target for Fulgent Genetic (FLGT)
www.americanbankingnews.com - June 15 at 4:34 PM
finance.yahoo.com logoFulgent Genetics, Inc. :FLGT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 6:28 PM
americanbankingnews.com logoFulgent Genetic (FLGT) Insider Purchases $149,400.00 in Stock
www.americanbankingnews.com - June 13 at 10:32 PM
americanbankingnews.com logoZacks: Fulgent Genetics Inc (FLGT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 30 at 10:47 PM
finance.yahoo.com logoWhy FULGENT GENETICS (FLGT) Could Be Positioned for a Slump
finance.yahoo.com - May 16 at 11:44 AM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - May 12 at 10:06 PM
finance.yahoo.com logoEdited Transcript of FLGT earnings conference call or presentation 8-May-17 9:00pm GMT
finance.yahoo.com - May 9 at 5:04 PM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Posts Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - May 9 at 4:32 PM
finance.yahoo.com logoInvestor Network: Fulgent Genetics, Inc. to Host Earnings Call
finance.yahoo.com - May 8 at 5:02 PM
finance.yahoo.com logoFulgent Genetics Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 8 at 5:02 PM
americanbankingnews.com logoZacks: Analysts Set $13.25 Price Target for Fulgent Genetics Inc (FLGT)
www.americanbankingnews.com - May 6 at 12:34 AM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Raised to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 27 at 6:34 PM
americanbankingnews.com logoZacks: Fulgent Genetics Inc (FLGT) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 20 at 8:28 PM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Short Interest Update
www.americanbankingnews.com - April 20 at 7:21 PM
finance.yahoo.com logoETFs with exposure to Fulgent Genetics, Inc. : April 19, 2017
finance.yahoo.com - April 19 at 5:07 PM
seekingalpha.com logoFulgent Genetics: The Next Big Healthcare Stock?
seekingalpha.com - April 8 at 9:46 AM
finance.yahoo.com logoETFs with exposure to Fulgent Genetics, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 5:08 PM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Downgraded to Sell at Zacks Investment Research
www.americanbankingnews.com - March 29 at 8:24 PM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - March 22 at 7:16 PM
americanbankingnews.com logoFulgent Genetics Inc's Lock-Up Period To End on March 28th (NASDAQ:FLGT)
www.americanbankingnews.com - March 21 at 7:07 AM
seekingalpha.com logoShort Fulgent Genetics; Major Stock Holders Could Sell At Lock-Up Expiration
seekingalpha.com - March 17 at 5:31 PM
biz.yahoo.com logoFULGENT GENETICS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 17 at 5:31 PM
americanbankingnews.com logoFulgent Genetics Inc (FLGT) Lifted to “Hold” at Zacks Investment Research
www.americanbankingnews.com - March 16 at 6:50 PM
biz.yahoo.com logoQ4 2016 Fulgent Genetics Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 1 at 9:57 PM
finance.yahoo.com logoFulgent Genetics to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
finance.yahoo.com - February 27 at 7:15 PM
globenewswire.com logoFulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
globenewswire.com - February 27 at 7:15 PM
seekingalpha.com logoFulgent Genetics beats by $0.02, misses on revenue
seekingalpha.com - February 27 at 7:15 PM
biz.yahoo.com logoFulgent Genetics Inc Earnings Call scheduled for 5:00 pm ET today
biz.yahoo.com - February 27 at 7:15 PM
finance.yahoo.com logoFulgent Genetics to Announce Fourth Quarter and Full Year 2016 Financial Results on February 27, 2017
finance.yahoo.com - February 16 at 5:10 PM
finance.yahoo.com logoFulgent Genetics, Inc. to Participate in Fireside Chat at the 28th Annual Piper Jaffray Healthcare Conference on November 29, 2016
finance.yahoo.com - November 15 at 8:21 AM
biz.yahoo.com logoFULGENT GENETICS, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 14 at 5:18 PM
finance.yahoo.com logoEdited Transcript of FLGT earnings conference call or presentation 3-Nov-16 9:00pm GMT
finance.yahoo.com - November 7 at 5:04 PM
biz.yahoo.com logoQ3 2016 Fulgent Genetics Inc Earnings Release - After Market Close
biz.yahoo.com - November 4 at 7:39 AM
biz.yahoo.com logoFULGENT GENETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
biz.yahoo.com - November 3 at 4:48 PM
nasdaq.com logoFulgent Genetics, Inc. to Announce Third Quarter 2016 Financial
www.nasdaq.com - October 28 at 4:53 PM
finance.yahoo.com logoFulgent Genetics, Inc. to Announce Third Quarter 2016 Financial Results on November 3, 2016
finance.yahoo.com - October 26 at 8:12 AM
finance.yahoo.com logoFulgent Genetics, Inc. to Present at the 25th Annual Credit Suisse Healthcare Conference on November 7, 2016
finance.yahoo.com - October 25 at 9:56 AM
finance.yahoo.com logoFulgent Is 'Making A Splash' In The Genetics Pool
finance.yahoo.com - October 24 at 4:52 PM
finance.yahoo.com logoFulgent Genetics 'Blazing a Different Path'; Piper Initiates At Overweight
finance.yahoo.com - October 24 at 4:52 PM
benzinga.com logoBTIG Initiates Fulgent Genetics At Buy; Co. Is A 'Rare Find' In Genetics
www.benzinga.com - October 24 at 10:17 AM
reuters.com logoFulgent Genetics Inc (FLGT.OQ)
www.reuters.com - October 17 at 5:00 PM
finance.yahoo.com logoFulgent Genetics, Inc. Announces Closing of Initial Public Offering
finance.yahoo.com - October 5 at 3:33 PM

Social

Chart

Fulgent Genetic (FLGT) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff